According to Bloomberg, Chinese AI startup Moonshot AI has formally issued a shareholder resolution to investors, planning to launch its initial public offering (IPO) in Hong Kong as soon as within the next six months. The company recently released its new open-weight model “Kimi K3,” which outperformed Western competitors on multiple frontier benchmarks, drawing significant market attention. Following this technological breakthrough, Moonshot AI is conducting a new round of financing, with its valuation expected to surpass $30 billion. As of June 2026, the company’s annualized recurring revenue (ARR) has reached $300 million, demonstrating strong growth momentum. This IPO plan marks a major milestone in the company’s development and reflects a broader shift in China’s AI industry from price wars to high-value technological competition.

Moonshot AI’s Technological Breakthrough Drives Revenue Surge, Valuation Tops $30 Billion

Following the launch of its new open-weight model “Kimi K3,” Moonshot AI saw a sharp surge in demand within 48 hours, prompting the company to suspend new user subscriptions to prioritize compute resources for existing members. Kimi K3 features 2.8 trillion parameters and is rated just behind Anthropic’s Claude Fable 5 and OpenAI’s GPT-5.6 in overall capabilities. Thanks to its technology premium, daily sales of the product grew at least sixfold after launch, pushing the company’s June annualized recurring revenue (ARR) to $300 million — significantly higher than the $200 million recorded in April. Moonshot AI is currently completing a new financing round, with market expectations placing its valuation above $30 billion.

Moonshot AI Actively Prepares for Hong Kong Listing

Sources indicate that the company has been preparing for a Hong Kong listing since early 2026 and has engaged in discussions with investment banks such as China International Capital Corporation (CICC) and Goldman Sachs. The formal issuance of the shareholder resolution signals that the IPO process has entered a substantive stage. If progress goes smoothly, this three-year-old startup could list in the capital markets within the next six months, becoming one of the first leading companies in China’s new wave of AI to go public.

China’s AI Market Upgrades, Moving Beyond Pure Price Competition

Moonshot AI’s rise and the pricing strategy of Kimi K3 demonstrate that China’s AI market is gradually moving away from past low-price competition. Kimi K3 is priced at a level comparable to Anthropic’s Sonnet, indicating growing market acceptance of premiums for high-end technology. According to evaluations by third-party organization Artificial Analysis, Kimi K3 surpassed Anthropic’s Opus 4.8 on certain frontier benchmarks, becoming the first Chinese open-weight model to achieve this milestone. This breakthrough shows that Chinese AI startups have gained the ability to commercialize and monetize high-end technology while catching up with top U.S. models.

Policy Support and Industry Competition Continue to Reshape the Market Landscape

The Beijing government is increasing support for domestic AI development. President Xi Jinping recently praised China’s progress in low-cost artificial intelligence and called for a more open global technology order, providing a favorable macro policy environment for Moonshot AI. However, market competition remains intense. Moonshot AI’s revenue scale is still smaller than that of its peer Z.AI (formerly Zhipu AI), whose annual sales are projected to reach $1 billion. Additionally, DeepSeek — which caused market turbulence in 2025 — also plans to pursue an IPO in 2027 and continues to seek new funding to expand its global market share. The technological iterations and capital deployments by first-tier companies such as Moonshot AI, Alibaba’s Tongyi Qianwen (Qwen), MiniMax, and Z.AI will continue to reshape the competitive landscape of the global AI industry.

Disclaimer: None of the information contained here constitutes an offer (or solicitation of an offer) to buy or sell any currency, product or financial instrument, to make any investment, or to participate in any particular trading strategy.